Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite ...
Exclusive: ASA calls number of parallel probes ‘significant’ and describes tackling issue as ‘priority’ after it issued ...
A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...
Outside the game, commercials are a big part of Super Bowl Sunday. Companies pay large amounts of money for their ...
The weight loss injection Mounjaro is a new treatment that can now be delivered to customers' homes by a new clinic service offered by Morrisons.
It shows visuals of existing weight loss medications known as GLP-1s, including injection pens that look like Novo Nordisk's blockbuster diabetes drug Ozempic ... an injection pen with distinctive ...